Background. Carfilzomib. lenalidomide. and dexamethasone (KRd) have been approved for the treatment of relapsed and refractory multiple myeloma (RRMM) based on ASPIRE clinical trial. https://www.ngetikin.com/limited-save-Apple-iPhone-14-Pro-Clear-Case-with-MagSafe-save-big/